bigger Created with Sketch.

News & Events

News & Events

To sign up for news alerts, please e-mail info@homologymedicines.com

For media inquiries, please email cmayfield@homologymedicines.com

News
& Events

Current News & Events | Archived News & Events
01/07/2019
Homology Medicines Achieves 2018 Goals and Prepares PKU Gene Therapy Program for the Clinic with Initial Data Expected in 2019​
01/07/2019
Homology Medicines Advances First Gene Editing Development Candidate into IND-Enabling Studies for Pediatric Patients with Phenylketonuria ​
11/13/2018
Homology Medicines Reports Third Quarter 2018 Financial Results​
11/08/2018
Homology Medicines Hosts Webinar on Gene Therapy and Gene Editing Approaches with the National PKU Alliance​
11/08/2018
Homology Medicines to Present at Stifel Healthcare Conference​
11/07/2018
Homology Medicines Presents Data on Platform’s Ability to Target the Central and Peripheral Nervous System and Therapeutic Potential in the Rare Disease Metachromatic Leukodystrophy ​
10/18/2018
Homology Medicines Presents Long-Term Efficacy Data of a Single Dose of Gene Therapy Development Candidate for Treatment of Phenylketonuria​
10/03/2018
Homology Medicines Announces President and CEO Arthur Tzianabos Elected to the Alliance for Regenerative Medicine’s Board of Directors​
10/01/2018
Homology Medicines to Present at Upcoming Conferences ​
08/30/2018
Homology Medicines to Participate in Gene Editing Panel at Citi’s Biotech Conference​
08/13/2018
Homology Medicines Reports Second Quarter 2018 Financial Results​
07/16/2018
Homology Medicines Announces Peer-Reviewed Publication Demonstrating Efficient and Precise In Vivo Gene Editing Capabilities of Nuclease-Free Technology Platform​
07/05/2018
Homology Medicines to Present at the National PKU Alliance Conference​
06/25/2018
Homology Medicines Added to the Russell 3000® and Russell 2000® Indexes​
06/04/2018
Homology Medicines Convenes Panel on Developing Genetic Medicines for Patients at BIO International Convention​
05/18/2018
Homology Medicines Presents Data from PKU Gene Therapy Program Demonstrating Long-Term Durability of Treatment in IND-Enabling Studies​
05/14/2018
Homology Medicines Reports First Quarter 2018 Financial Results​
05/10/2018
Homology Medicines Receives Award for Revolutionary New Therapeutic or Platform Startup from New England Venture Capital Association​
05/10/2018
Homology Medicines to Present at Bank of America Merrill Lynch Healthcare Conference​
05/01/2018
Homology Medicines Recognizes PKU Awareness Month​
04/30/2018
Homology Medicines Announces Upcoming Presentations on its Genetic Medicines Platform at the American Society of Gene & Cell Therapy Meeting​
04/23/2018
Homology Medicines to Participate in the World Orphan Drug Congress​
04/03/2018
Homology Medicines Announces Closing of Initial Public Offering​
03/27/2018
Homology Medicines Announces Pricing of Initial Public Offering​
03/15/2018
Homology Medicines Appoints Mary Thistle to Board of Directors​
03/01/2018
Homology Medicines Announces Peer-Reviewed Publication Indicating Low Prevalence of Pre-existing Neutralizing Antibodies to its Human-Derived AAVHSC Vectors​
02/28/2018
Homology Medicines Recognizes Rare Disease Day with Messages to the Patient Community​